Laennec – Japanese quality and safety. It is controlled by a state placental rehabilitation program running in Japan, managed and funded by a Department of Medicine. Laennec is a Japan’s state insurance medicine.
The high level of ecological and technological purification is granted. The selection of donors is controlled, so only a placenta of healthy women who’ve never left Japan and gave birth successfully is used.
The placenta undergoes a fine-grained examination in order to find any viruses, bacteria and prion proteins.
- Controlled by GMP standards,
- Providing qualitative purification and high stability of the drug’s active ingredients.
Graduated membranous osmolar dialysis and marking
The process of separation of active substances and peptides with molecular mass ranging from 200 D to 100 000 D via a molecular filter allows to withdraw the stem cells, hormones, structural proteins and blood proteins from the placental material.
Laennec is a guaranty of safety, stability and activity of the drug’s components.
The presence of regulatory peptides starting the cellular regeneration processes and structural components required for normal vital activity within the same drug ensures that the body restoration processes will run in the most adjusted to human physiology way.
Manufacture of Laennec is based on a multi-level molecular fractionation technology:
